{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:54:16Z","timestamp":1791071656138,"version":"4.1.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T00:00:00Z","timestamp":1388620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1003856","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T16:51:09Z","timestamp":1388681469000},"page":"e1003856","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":230,"title":["Enhancing Virus-Specific Immunity In Vivo by Combining Therapeutic Vaccination and PD-L1 Blockade in Chronic Hepadnaviral Infection"],"prefix":"10.1371","volume":"10","author":[{"given":"Jia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ejuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kosinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Seiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Glebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongliang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengji","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Roggendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,1,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(05)17701-0","article-title":"Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial","volume":"365","author":"HL Janssen","year":"2005","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa043470","article-title":"Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B","volume":"352","author":"GK Lau","year":"2005","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jhep.2005.11.036","article-title":"Cellular and virological mechanisms of HBV drug resistance","volume":"44","author":"S Locarnini","year":"2006","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","article-title":"Hepatitis B virus resistance to nucleos(t)ide analogues","volume":"137","author":"F Zoulim","year":"2009","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ni1241","article-title":"T cells and viral persistence: lessons from diverse infections","volume":"6","author":"P Klenerman","year":"2005","journal-title":"Nat Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/viro.1999.0130","article-title":"Vaccination to treat persistent viral infection","volume":"268","author":"MG von Herrath","year":"2000","journal-title":"Virology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/01.inf.0000059443.49414.8b","article-title":"Therapeutic vaccination in the immunotolerant phase of children with chronic hepatitis B infection","volume":"22","author":"B Dikici","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/jhep.2003.50474","article-title":"A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C","volume":"38","author":"F Nevens","year":"2003","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"8960","DOI":"10.1128\/JVI.79.14.8960-8968.2005","article-title":"Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination","volume":"79","author":"EJ Wherry","year":"2005","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jhep.2005.10.023","article-title":"Accumulation of dysfunctional effector CD8+ T cells in the liver of patients with chronic HCV infection","volume":"44","author":"C Nisii","year":"2006","journal-title":"J Hepatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"DL Barber","year":"2006","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.4049\/jimmunol.178.5.2714","article-title":"PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver","volume":"178","author":"H Maier","year":"2007","journal-title":"J Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nature07662","article-title":"Enhancing SIV-specific immunity in vivo by PD-1 blockade","volume":"458","author":"V Velu","year":"2009","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"980","DOI":"10.4049\/jimmunol.182.2.980","article-title":"PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccination","volume":"182","author":"AC Finnefrock","year":"2009","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1084\/jem.20061800","article-title":"Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade","volume":"203","author":"GJ Freeman","year":"2006","journal-title":"J Exp Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"C Boni","year":"2007","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"CL Day","year":"2006","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction","volume":"12","author":"L Trautmann","year":"2006","journal-title":"Nat Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1084\/jem.20061496","article-title":"PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection","volume":"203","author":"C Petrovas","year":"2006","journal-title":"J Exp Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep.21541","article-title":"Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection","volume":"45","author":"A Penna","year":"2007","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1053\/j.gastro.2007.06.059","article-title":"HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project)","volume":"133","author":"M Pilli","year":"2007","journal-title":"Gastroenterology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1084\/jem.20071949","article-title":"Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection","volume":"205","author":"SJ Ha","year":"2008","journal-title":"J Exp Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1128\/JVI.01613-07","article-title":"Combination of an antiviral drug and immunomodulation against hepadnaviral infection in the woodchuck model","volume":"82","author":"M Lu","year":"2008","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e26196","DOI":"10.1371\/journal.pone.0026196","article-title":"The expression of PD-1 ligands and their involvement in regulation of T cell functions in acute and chronic woodchuck hepatitis virus infection","volume":"6","author":"E Zhang","year":"2011","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"897","DOI":"10.4049\/jimmunol.162.2.897","article-title":"Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors","volume":"162","author":"DN Burshtyn","year":"1999","journal-title":"J Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ni0103-19","article-title":"The dual-function CD150 receptor subfamily: the viral attraction","volume":"4","author":"SP Sidorenko","year":"2003","journal-title":"Nat Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1053\/j.gastro.2008.03.037","article-title":"Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B","volume":"134","author":"Z Zhang","year":"2008","journal-title":"Gastroenterology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"7156","DOI":"10.1128\/JVI.02711-06","article-title":"Acute resolving woodchuck hepatitis virus (WHV) infection is associated with a strong cytotoxic T-lymphocyte response to a single WHV core peptide","volume":"81","author":"I Frank","year":"2007","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"9297","DOI":"10.1128\/JVI.00506-12","article-title":"DNA Prime-Adenovirus Boost Immunization Induces a Vigorous and Multifunctional T-Cell Response against Hepadnaviral Proteins in the Mouse and Woodchuck Model","volume":"86","author":"AD Kosinska","year":"2012","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e1003391","DOI":"10.1371\/journal.ppat.1003391","article-title":"Combination of DNA prime\u2013adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model","volume":"9","author":"AD Kosinska","year":"2013","journal-title":"PLoS pathogens"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T cell exhaustion during chronic viral infection","volume":"27","author":"EJ Wherry","year":"2007","journal-title":"Immunity"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1128\/JVI.78.11.5707-5719.2004","article-title":"Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy","volume":"78","author":"GJ Webster","year":"2004","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.191.8.1269","article-title":"The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection","volume":"191","author":"MK Maini","year":"2000","journal-title":"J Exp Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0140-6736(94)91384-6","article-title":"Specific vaccine therapy in chronic hepatitis B infection","volume":"344","author":"S Pol","year":"1994","journal-title":"Lancet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0168-8278(01)00028-9","article-title":"Efficacy and limitations of a specific immunotherapy in chronic hepatitis B","volume":"34","author":"S Pol","year":"2001","journal-title":"J Hepatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s15010-003-3187-1","article-title":"Specific hepatitis B vaccine therapy in inactive HBsAg carriers: a randomized controlled trial","volume":"31","author":"K Yalcin","year":"2003","journal-title":"Infection"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/80481","article-title":"Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques","volume":"6","author":"Z Hel","year":"2000","journal-title":"Nat Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.4049\/jimmunol.169.9.5347","article-title":"Vaccination of macaques with long-standing SIVmac251 infection lowers the viral set point after cessation of antiretroviral therapy","volume":"169","author":"E Tryniszewska","year":"2002","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2009.09.052","article-title":"Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B","volume":"138","author":"P Fisicaro","year":"2010","journal-title":"Gastroenterology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1073\/pnas.0801497105","article-title":"Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade","volume":"105","author":"SD Blackburn","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/cid\/cir334","article-title":"Clinical applications of DNA vaccines: current progress","volume":"53","author":"B Ferraro","year":"2011","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"SL Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"JR Brahmer","year":"2012","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.24249","article-title":"Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection","volume":"53","author":"A Schurich","year":"2011","journal-title":"Hepatology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/eji.201141852","article-title":"Blockade of Tim-3 signaling restores the virus-specific CD8(+) T-cell response in patients with chronic hepatitis B","volume":"42","author":"W Wu","year":"2012","journal-title":"European journal of immunology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.imlet.2012.12.004","article-title":"Expression of LAG-3 is coincident with the impaired effector function of HBV-specific CD8(+) T cell in HCC patients","volume":"150","author":"FJ Li","year":"2013","journal-title":"Immunology letters"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1053\/j.gastro.2013.02.003","article-title":"GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees","volume":"144","author":"RE Lanford","year":"2013","journal-title":"Gastroenterology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1128\/JVI.02384-08","article-title":"Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of interleukin-12","volume":"83","author":"J Crettaz","year":"2009","journal-title":"J Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1128\/JVI.73.1.281-289.1999","article-title":"Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection","volume":"73","author":"M Lu","year":"1999","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1128\/JVI.79.10.6368-6376.2005","article-title":"Immunization with the gene expressing woodchuck hepatitis virus nucleocapsid protein fused to cytotoxic-T-lymphocyte-associated antigen 4 leads to enhanced specific immune responses in mice and woodchucks","volume":"79","author":"M Lu","year":"2005","journal-title":"J Virol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/JVI.76.1.58-67.2002","article-title":"Woodchuck gamma interferon upregulates major histocompatibility complex class I transcription but is unable to deplete woodchuck hepatitis virus replication intermediates and RNAs in persistently infected woodchuck primary hepatocytes","volume":"76","author":"M Lu","year":"2002","journal-title":"J Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/j.1462-5822.2009.01353.x","article-title":"Lipopolysaccharide-induced innate immune responses in primary hepatocytes downregulates woodchuck hepatitis virus replication via interferon-independent pathways","volume":"11","author":"X Zhang","year":"2009","journal-title":"Cell Microbiol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1086\/324003","article-title":"Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection","volume":"184","author":"RJ Colonno","year":"2001","journal-title":"The Journal of infectious diseases"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1003856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T07:59:20Z","timestamp":1688889560000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1003856"}},"subtitle":[],"editor":[{"given":"Charles M.","family":"Rice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,2]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1003856","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718228106.793535780","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,2]]}}}